These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32109384)

  • 1. Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy.
    Misra C; Bangru S; Lin F; Lam K; Koenig SN; Lubbers ER; Hedhli J; Murphy NP; Parker DJ; Dobrucki LW; Cooper TA; Tajkhorshid E; Mohler PJ; Kalsotra A
    Dev Cell; 2020 Mar; 52(6):748-763.e6. PubMed ID: 32109384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible cardiac disease features in an inducible CUG repeat RNA-expressing mouse model of myotonic dystrophy.
    Rao AN; Campbell HM; Guan X; Word TA; Wehrens XH; Xia Z; Cooper TA
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33497365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
    Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
    PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant splicing and expression of the non muscle myosin heavy-chain gene MYH14 in DM1 muscle tissues.
    Rinaldi F; Terracciano C; Pisani V; Massa R; Loro E; Vergani L; Di Girolamo S; Angelini C; Gourdon G; Novelli G; Botta A
    Neurobiol Dis; 2012 Jan; 45(1):264-71. PubMed ID: 21872659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities.
    Poulin H; Mercier A; Djemai M; Pouliot V; Deschenes I; Boutjdir M; Puymirat J; Chahine M
    Sci Rep; 2021 Jan; 11(1):2500. PubMed ID: 33510259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
    Dastidar S; Ardui S; Singh K; Majumdar D; Nair N; Fu Y; Reyon D; Samara E; Gerli MFM; Klein AF; De Schrijver W; Tipanee J; Seneca S; Tulalamba W; Wang H; Chai YC; In't Veld P; Furling D; Tedesco FS; Vermeesch JR; Joung JK; Chuah MK; VandenDriessche T
    Nucleic Acids Res; 2018 Sep; 46(16):8275-8298. PubMed ID: 29947794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.
    Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S
    Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice.
    Lo Scrudato M; Poulard K; Sourd C; Tomé S; Klein AF; Corre G; Huguet A; Furling D; Gourdon G; Buj-Bello A
    Mol Ther; 2019 Aug; 27(8):1372-1388. PubMed ID: 31253581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal sodium current properties contribute to cardiac electrical and contractile dysfunction in a mouse model of myotonic dystrophy type 1.
    Algalarrondo V; Wahbi K; Sebag F; Gourdon G; Beldjord C; Azibi K; Balse E; Coulombe A; Fischmeister R; Eymard B; Duboc D; Hatem SN
    Neuromuscul Disord; 2015 Apr; 25(4):308-20. PubMed ID: 25613807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
    Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
    PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes.
    Dastidar S; Majumdar D; Tipanee J; Singh K; Klein AF; Furling D; Chuah MK; VandenDriessche T
    Mol Ther; 2022 Jan; 30(1):75-91. PubMed ID: 34371182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic ventricular fibrillation and the V1764fsX1786 frameshift mutation of the SCN5A gene in a myotonic dystrophy type 1 patient.
    Shimoyama T; Hayashi H; Suzuki F; Nishiyama Y; Miyamoto Y; Aiba T; Shimizu W; Kimura K
    J Clin Neurosci; 2020 Apr; 74():242-244. PubMed ID: 32063450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy.
    Mahadevan MS; Yadava RS; Yu Q; Balijepalli S; Frenzel-McCardell CD; Bourne TD; Phillips LH
    Nat Genet; 2006 Sep; 38(9):1066-70. PubMed ID: 16878132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients.
    Botta A; Rinaldi F; Catalli C; Vergani L; Bonifazi E; Romeo V; Loro E; Viola A; Angelini C; Novelli G
    J Med Genet; 2008 Oct; 45(10):639-46. PubMed ID: 18611984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis].
    Furling D
    Rinsho Shinkeigaku; 2012; 52(11):1018-22. PubMed ID: 23196502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
    Savkur RS; Philips AV; Cooper TA
    Nat Genet; 2001 Sep; 29(1):40-7. PubMed ID: 11528389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1.
    Azotla-Vilchis CN; Sanchez-Celis D; Agonizantes-Juárez LE; Suárez-Sánchez R; Hernández-Hernández JM; Peña J; Vázquez-Santillán K; Leyva-García N; Ortega A; Maldonado V; Rangel C; Magaña JJ; Cisneros B; Hernández-Hernández O
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33530452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myotonia and cardiac conduction defects in myotonic dystrophy and defect in ion channels].
    Kubota T; Nakamori M; Takahashi MP
    Rinsho Byori; 2014 Mar; 62(3):246-54. PubMed ID: 24800500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.